B+
Bull case
30%
Probability
Target price
$65.50
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
FTV
FortiveANYSE / Capital Goods
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$62.20
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$56.25
Analysis reference price unavailable
Analysis 2026-08-03 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-03
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+78.8
Score
AI commentary
The company-source evidence is concrete and constructive: Fortive raised guidance and reported strong Q2 growth, margins, cash flow, and buybacks. Market reaction was less supportive: the packet's July 29 MarketWatch headline reported relative underperformance versus competitors, while the available RankAlpha anchor was $59.21 on July 31. No exact event-day return or causal attribution is available, and no post-print analyst revision evidence was found. This remains a constructive but monitoring-style view.
RankAlpha Sentiment Codex - 2026-08-03
Open post-earnings memoEvidence flagged
later post-earnings follow-up lacks concrete company-source and analyst/market reaction evidence
Impact
tentative
Confidence
-
AI events
2026-07-29eventQ2 results and guidance raise support near-term reassessmentMedium impact
Fortive reported Q2 revenue growth of 7.9% reported and 6.7% core, adjusted EPS growth of 28.5%, adjusted EBITDA growth of 12%, and raised FY2026 adjusted EPS guidance to $2.95-$3.05 from $2.90-$3.00. The release also cited $271 million of quarterly free cash flow and approximately $200 million of buybacks. [#SEC-8K-2026-07-29]
2026-08-14catalystAdvanced Healthcare Solutions margin follow-throughMedium impact
Near-term sentiment may remain mixed if Advanced Healthcare Solutions margin softness persists: Q2 revenue grew 5.3% core, but adjusted EBITDA margin declined 80 basis points year over year, versus a 230-basis-point operating-margin expansion in Intelligent Operating Solutions. [#SEC-8K-2026-07-29]
2026-12-31catalystFortive Accelerated execution and capital returnsHigh impact
Management cited early evidence that innovation acceleration, commercial acceleration, recurring customer value, and FBS Amplified are improving growth and earnings. Buybacks totaled approximately $2 billion over the last four quarters. [#SEC-8K-2026-07-29]
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-03 • Updated nightlySource: Internal modelMethodology